Halliburton
HAL NYSE Oil & Gas Equipment & Services Financials FY2016–FY2025
Halliburton's revenue fell 3.3% to $22.2 billion in fiscal 2025. Its operating margin was 10.2%, down from 16.7% a year earlier. Free cash flow was $1.7 billion, down 31.0%. It paid out $1.6 billion in dividends and buybacks, 95% of free cash flow. The diluted share count fell 3.4%.
About these figures. Total debt is the balance sheet's long-term debt plus its current debt line.
What Halliburton does
Halliburton provides products and services to the energy industry. Its customers are oil and natural gas producers, from the major companies to national and independent ones. It helps them locate hydrocarbons, drill and evaluate wells, build and complete wells, and get more production from them over the life of a field. It has more than 46,000 employees in more than 70 countries.
It has two operating segments. Completion and Production covers cementing, stimulation (including hydraulic fracturing), specialty chemicals, well intervention, pressure control, artificial lift and completion products. Drilling and Evaluation covers drilling fluids, drill bits, directional drilling, wellbore placement and field and reservoir modeling and evaluation. Its revenue comes from selling these services and products to the energy industry. No single customer represented more than 10% of its consolidated revenue in any period presented.
Halliburton's total revenue decreased 3% in 2025 compared with 2024. In 2026 it plans to focus on international growth, its electric fracturing technology in North America, and digital and automation tools. It has described demand for its services as tied to the capital spending of oil and gas companies.
- Legal name
- HALLIBURTON COMPANY
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 6, 2026
- Accession · CIK
- 0000045012-26-000015
0000045012
Revenue and margins
Halliburton had $22.2B of revenue in fiscal 2025, down 3.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.7B in fiscal 2025, 7.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Halliburton returned $1.6B to shareholders in fiscal 2025, 95% of free cash flow. The diluted share count fell 3.4%.
Value Halliburton yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$5.1B and divides by 853.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today 23.3x · peers 25.6x · sector 16.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably Halliburton can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $3.0B | $2.3B | $2.3B | $2.6B | $2.2B |
| Debt incl. finance leases | $9.2B | $8.1B | $7.8B | $7.7B | $7.3B |
| Net debt / EBITDA | 2.3x | 1.6x | 1.1x | 1.0x | 1.5x |
| Debt / equity | 1.4x | 1.0x | 0.8x | 0.7x | 0.7x |
| Interest coverage | 3.5x | 5.6x | 8.9x | 8.7x | 5.2x |
| Current ratio | 2.3x | 2.1x | 2.1x | 2.1x | 2.0x |
| Quick ratio | 1.8x | 1.5x | 1.5x | 1.5x | 1.5x |
| Total assets | $22.3B | $23.3B | $24.7B | $25.6B | $25.0B |
| Total liabilities | $15.6B | $15.3B | $15.3B | $15.0B | $14.5B |
| Shareholders' equity | $6.7B | $7.9B | $9.4B | $10.5B | $10.5B |
| Net debt (− = net cash) | $6.2B | $5.7B | $5.5B | $5.1B | $5.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$25.4M
7 insiders
Of sales under plans
99%
$25.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Eric CarreEVP & Chief Financial Officer | Sold plan | 24,777 | $37.50 | $0.9M | Form 4 |
| Aug 19, 2026 | Jeffrey Shannon SlocumDirector, EVP and COO, Director | Sold plan | 52,572 | $35.09 | $1.8M | Form 4 |
| Aug 18, 2026 | Jeffrey Allen MillerDirector, President & CEO, Director | Sold plan | 124,483 | $35.00 | $4.4M | Form 4 |
| Aug 18, 2026 | Jeffrey Shannon SlocumDirector, EVP and COO, Director | Sold plan | 16,121 | $35.08 | $0.6M | Form 4 |
| Jun 18, 2026 | Eric CarreEVP & Chief Financial Officer | Sold plan | 24,778 | $35.89 | $0.9M | Form 4 |
| May 15, 2026 | Van H. BeckwithEVP, Secretary and CLO | Sold plan | 198,349 | $41.29 | $8.2M | Form 4 |
| May 5, 2026 | Michael Casey MaxwellPresident - Western Hemisphere | Sold plan | 20,348 | $41.89 | $0.9M | Form 4 |
| Apr 30, 2026 | Timothy McKeonSenior VP and Treasurer | Sold plan | 8,655 | $42.00 | $0.4M | Form 4 |
| Apr 30, 2026 | Tobi M. YoungDirector | Sold | 6,125 | $41.72 | $0.3M | Form 4 |
| Mar 27, 2026 | Jeffrey Allen MillerDirector, President & CEO, Director | Sold plan | 158,455 | $40.00 | $6.3M | Form 4 |
| Mar 16, 2026 | Jeffrey Shannon SlocumDirector, EVP and COO, Director | Sold plan | 5,441 | $33.82 | $0.2M | Form 4 |
| Mar 16, 2026 | Van H. BeckwithEVP, Secretary and CLO | Sold plan | 19,618 | $33.82 | $0.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✓ | ✓ | ✓ |
| Current ratio rose | ✓ | ✕ | ✕ |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | ✓ | ✕ | ✕ |
| F-score | 8 / 8 | 5 / 8 | 5 / 8 |
| Accruals ratio | −3.4% | −5.4% | −6.5% |
| Altman Z'' | 4.99 | 5.19 | 4.85 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Halliburton HAL | $29.1B | −3.3% | 10.2% | 7.5% | 10.5% | 23.3x | 5 | |
| Baker Hughes BKR | — | −0.3% | — | 9.2% | 14.1% | — | — | Compare → |
| Schlumberger SLB | $79.9B | −1.6% | — | 13.4% | 12.7% | 25.6x | 4 | Compare → |
| TechnipFMC FTI | $28.3B | 9.4% | 14.5% | 14.6% | 37.2% | 24.3x | 8 | Compare → |
| NOV NOV | $7.2B | −1.4% | 5.7% | 10.0% | 3.5% | 79.0x | 5 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $15.9B | $20.6B | $24.0B | $22.4B | $14.4B | $15.3B | $20.3B | $23.0B | $22.9B | $22.2B |
| Gross profit | $12.1B | $16.5B | — | — | — | — | — | — | — | — |
| Research and development | $329M | $360M | $390M | $404M | $309M | $321M | $345M | $408M | $426M | $411M |
| Operating income | −$6.8B | $1.4B | $2.5B | −$448M | −$2.4B | $1.8B | $2.7B | $4.1B | $3.8B | $2.3B |
| Interest expense | $659M | $594M | $556M | $534M | $509M | $517M | $487M | $460M | $441M | $432M |
| Pretax income | −$7.6B | $682M | $1.8B | −$1.1B | −$3.2B | $1.3B | $2.1B | $3.4B | $3.2B | $1.8B |
| Income tax | −$1.9B | $1.1B | $157M | $7.0M | −$278M | −$216M | $515M | $701M | $718M | $479M |
| Net income | −$5.8B | −$463M | $1.7B | −$1.1B | −$2.9B | $1.5B | $1.6B | $2.6B | $2.5B | $1.3B |
| Diluted EPS | −$6.69 | −$0.53 | $1.89 | −$1.29 | −$3.34 | $1.63 | $1.73 | $2.92 | $2.83 | $1.50 |
| Diluted shares | 0.86B | 0.87B | 0.88B | 0.88B | 0.88B | 0.89B | 0.91B | 0.90B | 0.88B | 0.85B |
| Cash flow | ||||||||||
| Cash from operations | −$1.7B | $2.5B | $3.2B | $2.4B | $1.9B | $1.9B | $2.2B | $3.5B | $3.9B | $2.9B |
| Capital expenditure | $798M | $1.4B | $2.0B | $1.5B | $728M | $799M | $1.0B | $1.4B | $1.4B | $1.3B |
| Free cash flow | −$2.5B | $1.1B | $1.1B | $915M | $1.2B | $1.1B | $1.2B | $2.1B | $2.4B | $1.7B |
| Depreciation and amortization | $1.5B | $1.6B | $1.6B | $1.6B | $1.1B | $904M | $940M | $998M | $1.1B | $1.1B |
| Acquisitions | $31.0M | $628M | $187M | $0.0M | $0.0M | $0.0M | $0.0M | $13.0M | $27.0M | $185M |
| Share buybacks | $0.0M | $0.0M | $400M | $100M | $100M | $0.0M | $250M | $800M | $1.0B | $1.0B |
| Dividends paid | $620M | $626M | $630M | $630M | $278M | $161M | $435M | $576M | $600M | $579M |
| Dividends and buybacks | $620M | $626M | $1.0B | $730M | $378M | $161M | $685M | $1.4B | $1.6B | $1.6B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $4.0B | $2.3B | $2.0B | $2.3B | $2.6B | $3.0B | $2.3B | $2.3B | $2.6B | $2.2B |
| Total debt | $12.4B | $10.9B | $10.3B | $10.3B | $9.8B | $9.1B | $7.9B | $7.6B | $7.5B | $7.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $143M | $142M | $111M | $141M | $164M | $170M | $183M |
| Current assets | $11.7B | $10.8B | $11.2B | $11.2B | $9.5B | $9.9B | $11.0B | $11.5B | $12.4B | $11.4B |
| Current liabilities | $4.0B | $4.9B | $4.8B | $4.9B | $4.4B | $4.3B | $5.3B | $5.6B | $6.1B | $5.6B |
| Inventory | $2.3B | $2.4B | $3.0B | $3.1B | $2.3B | $2.4B | $2.9B | $3.2B | $3.0B | $3.0B |
| Property and equipment, net | $8.5B | $8.5B | $8.9B | $7.3B | $4.3B | $4.3B | $4.3B | $4.9B | $5.1B | $5.3B |
| Total assets | $27.0B | $25.1B | $26.0B | $25.4B | $20.7B | $22.3B | $23.3B | $24.7B | $25.6B | $25.0B |
| Total liabilities | $17.6B | $16.7B | $16.4B | $17.4B | $15.7B | $15.6B | $15.3B | $15.3B | $15.0B | $14.5B |
| Shareholders' equity | $9.4B | $8.3B | $9.5B | $8.0B | $5.0B | $6.7B | $7.9B | $9.4B | $10.5B | $10.5B |
| Margins | ||||||||||
| Gross margin | 76.3% | 79.9% | — | — | — | — | — | — | — | — |
| Operating margin | −42.6% | 6.7% | 10.3% | −2.0% | −16.9% | 11.8% | 13.3% | 17.7% | 16.7% | 10.2% |
| EBITDA margin | −33.2% | 14.2% | 17.0% | 5.3% | −9.5% | 17.7% | 18.0% | 22.1% | 21.4% | 15.3% |
| Net margin | −36.3% | −2.3% | 6.9% | −5.1% | −20.4% | 9.5% | 7.7% | 11.5% | 10.9% | 5.8% |
| FCF margin | −15.7% | 5.3% | 4.7% | 4.1% | 8.0% | 7.3% | 6.1% | 9.0% | 10.6% | 7.5% |
| Returns | ||||||||||
| Return on capital | −27.7% | 4.0% | 12.9% | −2.1% | −13.5% | 14.2% | 15.4% | 22.6% | 19.4% | 10.5% |
| Return on capital employed | −24.8% | 6.4% | 11.9% | −2.2% | −13.3% | 10.5% | 15.1% | 22.1% | 19.8% | 11.6% |
| Return on equity | −46.3% | −5.2% | 18.6% | −12.9% | −45.4% | 24.9% | 21.4% | 30.4% | 25.1% | 12.2% |
| Return on assets | −18.0% | −1.8% | 6.5% | −4.4% | −12.8% | 6.8% | 6.9% | 11.0% | 10.0% | 5.1% |
| Growth | ||||||||||
| Revenue growth | −32.8% | 29.8% | 16.4% | −6.6% | −35.5% | 5.9% | 32.7% | 13.4% | −0.3% | −3.3% |
| Net income growth | — | — | — | −168.3% | — | — | 7.9% | 67.8% | −5.2% | −48.7% |
| EPS growth | — | — | — | −168.3% | — | — | 6.1% | 68.8% | −3.1% | −47.0% |
| FCF growth | −446.4% | — | 3.3% | −19.1% | 26.0% | −3.6% | 10.7% | 68.9% | 16.6% | −31.0% |
| Share count change | 0.9% | 1.1% | 0.8% | −0.2% | 0.7% | 1.3% | 1.8% | −0.7% | −2.1% | −3.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | — | 2.9x | 2.1x | 7.0x | — | 2.3x | 1.6x | 1.1x | 1.0x | 1.5x |
| Debt / equity | 1.3x | 1.3x | 1.1x | 1.3x | 2.0x | 1.4x | 1.0x | 0.8x | 0.7x | 0.7x |
| Interest coverage | −10.3x | 2.3x | 4.4x | −0.8x | −4.8x | 3.5x | 5.6x | 8.9x | 8.7x | 5.2x |
| Current ratio | 2.9x | 2.2x | 2.3x | 2.3x | 2.1x | 2.3x | 2.1x | 2.1x | 2.1x | 2.0x |
| Quick ratio | 2.3x | 1.7x | 1.7x | 1.7x | 1.6x | 1.8x | 1.5x | 1.5x | 1.5x | 1.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.0% | 6.7% | 8.4% | 6.8% | 5.0% | 5.2% | 5.0% | 6.0% | 6.3% | 5.7% |
| Payouts / FCF | — | 57.2% | 91.1% | 79.8% | 32.8% | 14.5% | 55.7% | 66.2% | 66.2% | 94.9% |
| Quality scores | ||||||||||
| Piotroski F-score | 2.0 | 5.0 | 7.0 | 4.0 | 2.0 | 7.0 | 5.0 | 8.0 | 5.0 | 5.0 |
| Altman Z'' | 2.5 | 4.1 | 4.6 | 3.5 | 2.5 | 4.1 | 4.4 | 5.0 | 5.2 | 4.9 |
| Accruals ratio | −12.7% | −11.3% | −5.9% | −13.9% | −21.0% | −2.1% | −2.9% | −3.4% | −5.4% | −6.5% |
Source: SEC EDGAR XBRL filings (CIK 0000045012). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.